Kaiser Permanente-San Francisco — San Francisco, California

Kaiser Permanente-San Francisco is a clinical research site located in San Francisco, California, United States 94115.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

Kaiser Permanente-San Francisco has participated in 202 clinical trials with 125 currently active.

Therapeutic areas: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Plasma Cell Myeloma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, Wake Forest University Health Sciences.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kaiser Permanente-San Francisco?

Kaiser Permanente-San Francisco has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kaiser Permanente-San Francisco conducted?

Kaiser Permanente-San Francisco has 202 clinical trials on record, with 125 currently active. Their work covers Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Plasma Cell Myeloma.

Is Kaiser Permanente-San Francisco accredited by Crixeo Health?

Kaiser Permanente-San Francisco has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kaiser Permanente-San Francisco?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.